&nbsp;

Oct 2022

Drug

DACTINomycin

Other Name(s): Cosmegen®

Quick Link(s):

Jan 2022

Drug

lapatinib

Other Name(s): Tykerb®

Quick Link(s):

Dec 2022

Drug

carmustine

Other Name(s): BiCNU®

Quick Link(s):

Patient Info Sheet

Oct 2022

Drug

methotrexate

Quick Link(s):

Nov 2022

Drug

crizotinib

Other Name(s): Xalkori®

Quick Link(s):

Jan 2022

Drug

PERTuzumab

Other Name(s): Perjeta®

Quick Link(s):

Sep 2022

Drug

idelalisib

Other Name(s): Zydelig™

Quick Link(s):

Feb 2022

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s):

Jun 2022

Regimen

ALDE(Intralesional)

Cancer Type:

Skin,

Melanoma

Intent: Palliative, Curative

Funding:

New Drug Funding Program

Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma

, Collapse Show fewer tags

Drugs Used:

aldesleukin

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

Regimen

ETOPPAC-CISPPACL

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

, Collapse Show fewer tags

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2019

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria